Darling Ingredients and Tessenderlo Group Advance Strategic Partnership With Definitive Agreement to Form New Global Collagen Company Darling Ingredients announced that it has entered into a definitive agreement with Tessenderlo Group to formally combine the collagen and gelatin divisions of…
Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America, Expanding Access to Pathogen Reduction Technologies CONCORD Calif Cerus Corporation announced that it has finalized a new group purchasing agreement with Blood Centers of America the largest blood supply…
Elevance Health Announces Appointment of Amy Schulman as Independent Director Elevance Health announced today that its board of directors has appointed Amy Schulman, a widely respected healthcare executive, seasoned investor, and experienced governance leader, as an independent director effective January…
Mainstay Healthcare Partners Forms Strategic Advisory Board, Adding Deep Industry Expertise to Strengthen Growth and Capital Markets Advisory Platforms Mainstay Healthcare Partners (“Mainstay”), a strategic advisory and investment firm supporting healthcare services and health technology organizations, today announced the formation…
Medicare Advantage Employer-Group Market Shows Steady Growth as MFA Analyzes 2025 Trends The employer-group Medicare Advantage (MA) market continued to demonstrate stability and gradual growth heading into late 2025, according to newly released insights from Mark Farrah Associates (MFA). Drawing…
Nephrodite Achieves Major Breakthrough as Holly Device Delivers Continuous Kidney Function in Multi-Day Large Animal Study Nephrodite a medical device innovator advancing an implantable, fully mechanical renal replacement system, has announced highly encouraging results from a landmark multi-day large animal…
Duly Health and Care is strengthening its commitment to delivering accessible, affordable, and high-quality care across the communities it serves by hosting a comprehensive Primary Care Health Fair on Friday, December 13, from 10 AM to 12 PM at 1034…
Qihan Biotech Presents Promising Clinical and Preclinical Data on Allogeneic and In Vivo CAR-T Programs at the 67th ASH Annual Meeting Qihan Biotech, a clinical-stage biotechnology company developing off-the-shelf cell therapies for autoimmune diseases and cancer, announced new clinical and…
Ossium Health to Report New Clinical Evidence Supporting Organ Donor Bone Marrow Platform at ASH 2025 a bioengineering company that pioneered the world’s first on-demand bank of organ donor–derived bone marrow, announced it will present new clinical data at the…
Stoke and Biogen Share New Zorevunersen Data in Dravet Syndrome Stoke Therapeutics and Biogen have announced new long-term clinical data that continue to strengthen the evidence supporting zorevunersen as a potential first-in-class disease-modifying therapy for Dravet syndrome. The data were…